To evaluate maternal glucose levels during pregnancy as a predictor of adverse perinatal outcomes in Dar es Salaam, Tanzania.
Methods
Random blood glucose measurements were analyzed from 3833 pregnant women enrolled in a randomized trial to assess the impact of multivitamins on pregnancy outcomes in Dar es Salaam between August 2001 and July 2004. Information on maternal and neonatal morbidity was recorded at monthly study visits, delivery, and 6 weeks postpartum. Generalized estimating equations specified with a binomial distribution and log-link function were used to determine the relationship between elevated glucose (>7.8 mmol/L) and pregnancy outcomes.
Results
In total, 25 women had elevated glucose (0.7%). Hyperglycemia was associated with an increased risk of delivery before 37 weeks [relative risk (RR), 2.11; 95% confidence interval [CI], 1.07–4.13; P=0.03), delivery before 34 weeks (RR, 4.15; 95% CI, 1.43–12.03, P=0.009), incident gestational hypertension (RR, 2.90; 95% CI, 1.24–6.76; P=0.01), low birth weight (RR, 2.87; 95% CI, 1.18–6.99; P=0.02), reduced newborn head circumference (mean difference, –1.53; 95% CI, –2.51 to –0.62; P=0.001), and stillbirth (RR, 3.38; 95% CI, 1.13–10.08; P=0.03).
Conclusion
Maternal hyperglycemia is uncommon among pregnant Tanzanian women, but nonetheless seems to increase the risk of several adverse perinatal outcomes.
